Tag archive for ‘120 mg and 240 mg’
By editor3 On Wednesday, October 7th, 2020
0 Comments

Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg

Mumbai, October 07, 2020. Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Dimethyl Fumarate Delayed-Release Capsules, More...

Live Updates COVID-19 CASES